<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To clarify the relation between neuronal protection against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> and calcium/calmodulin-dependent protein kinase II (CaM kinase II) activity, we investigated temporal alterations of the kinase activity in the hippocampus after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> under neuroprotective conditions, employing the gerbil bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="1" pm="."><plain>The hippocampal CA1 neuronal density at 2 hours after 5 minutes of forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> was 214.7 +/- 25.8/mm (mean +/- S.D.), and did not differ from the control significantly; however, it decreased to 11.7 +/- 4.2/mm at 7 days after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The neuronal density at 7 days after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> was 185.1 +/- 18.5 under the hypothermic conditions, 128.7 +/- 19.6 with the brief ischaemic pretreatment, 65.0 +/- 13.4 with administration of MK-801, and 20.5 +/- 4.2 with the repetitive hyperthermic pretreatment, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/calmodulin-dependent activity of CaM kinase II in the hippocampal cytosolic fraction was decreased to 47.5% of the control value at 2 hours after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>, when CA1 neuronal <z:hpo ids='HP_0011420'>death</z:hpo> was not observed </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, the activity was 98.8% of the control under the hypothermic conditions, 91.4% with the brief ischaemic pretreatment, 71.2% with administration of MK-801, and 47.9% with the repetitive hyperthermic pretreatment, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicated that the preservation of the <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/calmodulin-dependent activity of cytosolic CaM kinase II after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> parallelled the neuroprotective effect in the gerbil hippocampus </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, it is suggested that the preservation of the activity may be involved in the mechanism of neuronal protection against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
</text></document>